0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nivolumab Injection Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-27N7625
Home | Market Reports | Health | Health Conditions | Cancer
Global Nivolumab Injection Market Insights and Forecast to 2028

Global Nivolumab Injection Market Insights and Forecast to 2028

Code: QYRE-Auto-27N7625
Report
May 2022
92 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Nivolumab Injection is suitable for treating adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are negative for mutations in the epidermal growth factor receptor (EGFR) gene and negative for anaplastic lymphoma kinase (ALK), who have previously undergone platinum-containing chemotherapy and whose disease has progressed or is intolerable.
Market Analysis and Insights: Global Nivolumab Injection Market

Due to the COVID-19 pandemic, the global Nivolumab Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, 100IU accounting for % of the Nivolumab Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Unresectable Melanoma segment is altered to an % CAGR throughout this forecast period.
China Nivolumab Injection market size is valued at US$ million in 2021, while the US and Europe Nivolumab Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Nivolumab Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Nivolumab Injection include AbbVie, Allergan, Ono Pharmaceutical, Sinopharm and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Nivolumab Injection Scope and Segment
Nivolumab Injection market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nivolumab Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

100IU
50IU
Other

Segment by Application

Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other

BY COMPANY

AbbVie
Allergan
Ono Pharmaceutical
Sinopharm
Bristol-Myers Squibb

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Nivolumab Injection Product Introduction
1.2 Market by Type
1.2.1 Global Nivolumab Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100IU
1.2.3 50IU
1.2.4 Other
1.3 Market by Application
1.3.1 Global Nivolumab Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Unresectable Melanoma
1.3.3 Metastatic Melanoma
1.3.4 Metastatic Squamous NSCLC
1.3.5 Classical Hodgkin Lymphoma
1.3.6 Renal Cell Carcinoma
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nivolumab Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Nivolumab Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Nivolumab Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nivolumab Injection Sales by Region
2.4.1 Global Nivolumab Injection Sales by Region (2017-2022)
2.4.2 Global Sales Nivolumab Injection by Region (2023-2028)
2.5 Global Nivolumab Injection Revenue by Region
2.5.1 Global Nivolumab Injection Revenue by Region (2017-2022)
2.5.2 Global Nivolumab Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nivolumab Injection Sales by Manufacturers
3.1.1 Global Top Nivolumab Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Nivolumab Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nivolumab Injection in 2021
3.2 Global Nivolumab Injection Revenue by Manufacturers
3.2.1 Global Nivolumab Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Nivolumab Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nivolumab Injection Revenue in 2021
3.3 Global Nivolumab Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nivolumab Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nivolumab Injection Sales by Type
4.1.1 Global Nivolumab Injection Historical Sales by Type (2017-2022)
4.1.2 Global Nivolumab Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Nivolumab Injection Sales Market Share by Type (2017-2028)
4.2 Global Nivolumab Injection Revenue by Type
4.2.1 Global Nivolumab Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Nivolumab Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nivolumab Injection Revenue Market Share by Type (2017-2028)
4.3 Global Nivolumab Injection Price by Type
4.3.1 Global Nivolumab Injection Price by Type (2017-2022)
4.3.2 Global Nivolumab Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nivolumab Injection Sales by Application
5.1.1 Global Nivolumab Injection Historical Sales by Application (2017-2022)
5.1.2 Global Nivolumab Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Nivolumab Injection Sales Market Share by Application (2017-2028)
5.2 Global Nivolumab Injection Revenue by Application
5.2.1 Global Nivolumab Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Nivolumab Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nivolumab Injection Revenue Market Share by Application (2017-2028)
5.3 Global Nivolumab Injection Price by Application
5.3.1 Global Nivolumab Injection Price by Application (2017-2022)
5.3.2 Global Nivolumab Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nivolumab Injection Market Size by Type
6.1.1 North America Nivolumab Injection Sales by Type (2017-2028)
6.1.2 North America Nivolumab Injection Revenue by Type (2017-2028)
6.2 North America Nivolumab Injection Market Size by Application
6.2.1 North America Nivolumab Injection Sales by Application (2017-2028)
6.2.2 North America Nivolumab Injection Revenue by Application (2017-2028)
6.3 North America Nivolumab Injection Market Size by Country
6.3.1 North America Nivolumab Injection Sales by Country (2017-2028)
6.3.2 North America Nivolumab Injection Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Nivolumab Injection Market Size by Type
7.1.1 Europe Nivolumab Injection Sales by Type (2017-2028)
7.1.2 Europe Nivolumab Injection Revenue by Type (2017-2028)
7.2 Europe Nivolumab Injection Market Size by Application
7.2.1 Europe Nivolumab Injection Sales by Application (2017-2028)
7.2.2 Europe Nivolumab Injection Revenue by Application (2017-2028)
7.3 Europe Nivolumab Injection Market Size by Country
7.3.1 Europe Nivolumab Injection Sales by Country (2017-2028)
7.3.2 Europe Nivolumab Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nivolumab Injection Market Size by Type
8.1.1 Asia Pacific Nivolumab Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Nivolumab Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Nivolumab Injection Market Size by Application
8.2.1 Asia Pacific Nivolumab Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Nivolumab Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Nivolumab Injection Market Size by Region
8.3.1 Asia Pacific Nivolumab Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Nivolumab Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Nivolumab Injection Market Size by Type
9.1.1 Latin America Nivolumab Injection Sales by Type (2017-2028)
9.1.2 Latin America Nivolumab Injection Revenue by Type (2017-2028)
9.2 Latin America Nivolumab Injection Market Size by Application
9.2.1 Latin America Nivolumab Injection Sales by Application (2017-2028)
9.2.2 Latin America Nivolumab Injection Revenue by Application (2017-2028)
9.3 Latin America Nivolumab Injection Market Size by Country
9.3.1 Latin America Nivolumab Injection Sales by Country (2017-2028)
9.3.2 Latin America Nivolumab Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Nivolumab Injection Market Size by Type
10.1.1 Middle East and Africa Nivolumab Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nivolumab Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Nivolumab Injection Market Size by Application
10.2.1 Middle East and Africa Nivolumab Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nivolumab Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Nivolumab Injection Market Size by Country
10.3.1 Middle East and Africa Nivolumab Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nivolumab Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Nivolumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Nivolumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Ono Pharmaceutical
11.3.1 Ono Pharmaceutical Corporation Information
11.3.2 Ono Pharmaceutical Overview
11.3.3 Ono Pharmaceutical Nivolumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Ono Pharmaceutical Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ono Pharmaceutical Recent Developments
11.4 Sinopharm
11.4.1 Sinopharm Corporation Information
11.4.2 Sinopharm Overview
11.4.3 Sinopharm Nivolumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sinopharm Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sinopharm Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Corporation Information
11.5.2 Bristol-Myers Squibb Overview
11.5.3 Bristol-Myers Squibb Nivolumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bristol-Myers Squibb Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers Squibb Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nivolumab Injection Industry Chain Analysis
12.2 Nivolumab Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nivolumab Injection Production Mode & Process
12.4 Nivolumab Injection Sales and Marketing
12.4.1 Nivolumab Injection Sales Channels
12.4.2 Nivolumab Injection Distributors
12.5 Nivolumab Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nivolumab Injection Industry Trends
13.2 Nivolumab Injection Market Drivers
13.3 Nivolumab Injection Market Challenges
13.4 Nivolumab Injection Market Restraints
14 Key Findings in The Global Nivolumab Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Nivolumab Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 100IU
    Table 3. Major Manufacturers of 50IU
    Table 4. Major Manufacturers of Other
    Table 5. Global Nivolumab Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Nivolumab Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Nivolumab Injection Sales by Region (2017-2022) & (K Units)
    Table 8. Global Nivolumab Injection Sales Market Share by Region (2017-2022)
    Table 9. Global Nivolumab Injection Sales by Region (2023-2028) & (K Units)
    Table 10. Global Nivolumab Injection Sales Market Share by Region (2023-2028)
    Table 11. Global Nivolumab Injection Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Nivolumab Injection Revenue Market Share by Region (2017-2022)
    Table 13. Global Nivolumab Injection Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Nivolumab Injection Revenue Market Share by Region (2023-2028)
    Table 15. Global Nivolumab Injection Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Nivolumab Injection Sales Share by Manufacturers (2017-2022)
    Table 17. Global Nivolumab Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Nivolumab Injection Revenue Share by Manufacturers (2017-2022)
    Table 19. Nivolumab Injection Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Nivolumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Nivolumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nivolumab Injection as of 2021)
    Table 22. Nivolumab Injection Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Nivolumab Injection Product Offered
    Table 24. Date of Manufacturers Enter into Nivolumab Injection Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Nivolumab Injection Sales by Type (2017-2022) & (K Units)
    Table 27. Global Nivolumab Injection Sales by Type (2023-2028) & (K Units)
    Table 28. Global Nivolumab Injection Sales Share by Type (2017-2022)
    Table 29. Global Nivolumab Injection Sales Share by Type (2023-2028)
    Table 30. Global Nivolumab Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Nivolumab Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Nivolumab Injection Revenue Share by Type (2017-2022)
    Table 33. Global Nivolumab Injection Revenue Share by Type (2023-2028)
    Table 34. Nivolumab Injection Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Nivolumab Injection Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Nivolumab Injection Sales by Application (2017-2022) & (K Units)
    Table 37. Global Nivolumab Injection Sales by Application (2023-2028) & (K Units)
    Table 38. Global Nivolumab Injection Sales Share by Application (2017-2022)
    Table 39. Global Nivolumab Injection Sales Share by Application (2023-2028)
    Table 40. Global Nivolumab Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Nivolumab Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Nivolumab Injection Revenue Share by Application (2017-2022)
    Table 43. Global Nivolumab Injection Revenue Share by Application (2023-2028)
    Table 44. Nivolumab Injection Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Nivolumab Injection Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Nivolumab Injection Sales by Type (2017-2022) & (K Units)
    Table 47. North America Nivolumab Injection Sales by Type (2023-2028) & (K Units)
    Table 48. North America Nivolumab Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Nivolumab Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Nivolumab Injection Sales by Application (2017-2022) & (K Units)
    Table 51. North America Nivolumab Injection Sales by Application (2023-2028) & (K Units)
    Table 52. North America Nivolumab Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Nivolumab Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Nivolumab Injection Sales by Country (2017-2022) & (K Units)
    Table 55. North America Nivolumab Injection Sales by Country (2023-2028) & (K Units)
    Table 56. North America Nivolumab Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Nivolumab Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Nivolumab Injection Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Nivolumab Injection Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Nivolumab Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Nivolumab Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Nivolumab Injection Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Nivolumab Injection Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Nivolumab Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Nivolumab Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Nivolumab Injection Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Nivolumab Injection Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Nivolumab Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Nivolumab Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Nivolumab Injection Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Nivolumab Injection Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Nivolumab Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Nivolumab Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Nivolumab Injection Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Nivolumab Injection Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Nivolumab Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Nivolumab Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Nivolumab Injection Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Nivolumab Injection Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Nivolumab Injection Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Nivolumab Injection Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Nivolumab Injection Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Nivolumab Injection Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Nivolumab Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Nivolumab Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Nivolumab Injection Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Nivolumab Injection Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Nivolumab Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Nivolumab Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Nivolumab Injection Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Nivolumab Injection Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Nivolumab Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Nivolumab Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Nivolumab Injection Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Nivolumab Injection Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Nivolumab Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Nivolumab Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Nivolumab Injection Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Nivolumab Injection Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Nivolumab Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Nivolumab Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Nivolumab Injection Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Nivolumab Injection Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Nivolumab Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Nivolumab Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 106. AbbVie Corporation Information
    Table 107. AbbVie Description and Major Businesses
    Table 108. AbbVie Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. AbbVie Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. AbbVie Recent Developments
    Table 111. Allergan Corporation Information
    Table 112. Allergan Description and Major Businesses
    Table 113. Allergan Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. Allergan Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Allergan Recent Developments
    Table 116. Ono Pharmaceutical Corporation Information
    Table 117. Ono Pharmaceutical Description and Major Businesses
    Table 118. Ono Pharmaceutical Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Ono Pharmaceutical Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Ono Pharmaceutical Recent Developments
    Table 121. Sinopharm Corporation Information
    Table 122. Sinopharm Description and Major Businesses
    Table 123. Sinopharm Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. Sinopharm Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Sinopharm Recent Developments
    Table 126. Bristol-Myers Squibb Corporation Information
    Table 127. Bristol-Myers Squibb Description and Major Businesses
    Table 128. Bristol-Myers Squibb Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. Bristol-Myers Squibb Nivolumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Bristol-Myers Squibb Recent Developments
    Table 131. Key Raw Materials Lists
    Table 132. Raw Materials Key Suppliers Lists
    Table 133. Nivolumab Injection Distributors List
    Table 134. Nivolumab Injection Customers List
    Table 135. Nivolumab Injection Market Trends
    Table 136. Nivolumab Injection Market Drivers
    Table 137. Nivolumab Injection Market Challenges
    Table 138. Nivolumab Injection Market Restraints
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nivolumab Injection Product Picture
    Figure 3. Global Nivolumab Injection Market Share by Type in 2021 & 2028
    Figure 3. 100IU Product Picture
    Figure 4. 50IU Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Nivolumab Injection Market Share by Application in 2021 & 2028
    Figure 7. Unresectable Melanoma
    Figure 8. Metastatic Melanoma
    Figure 9. Metastatic Squamous NSCLC
    Figure 10. Classical Hodgkin Lymphoma
    Figure 11. Renal Cell Carcinoma
    Figure 12. Other
    Figure 13. Nivolumab Injection Report Years Considered
    Figure 14. Global Nivolumab Injection Sales 2017-2028 (K Units)
    Figure 15. Global Nivolumab Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Nivolumab Injection Revenue 2017-2028 (US$ Million)
    Figure 17. Global Nivolumab Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Nivolumab Injection Sales Market Share by Region (2017-2022)
    Figure 19. Global Nivolumab Injection Sales Market Share by Region (2023-2028)
    Figure 20. North America Nivolumab Injection Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Nivolumab Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Nivolumab Injection Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Nivolumab Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Nivolumab Injection Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Nivolumab Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Nivolumab Injection Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Nivolumab Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Nivolumab Injection Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Nivolumab Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Nivolumab Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Nivolumab Injection in the World: Market Share by Nivolumab Injection Revenue in 2021
    Figure 32. Global Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Nivolumab Injection Sales Market Share by Type (2017-2028)
    Figure 34. Global Nivolumab Injection Revenue Market Share by Type (2017-2028)
    Figure 35. Global Nivolumab Injection Sales Market Share by Application (2017-2028)
    Figure 36. Global Nivolumab Injection Revenue Market Share by Application (2017-2028)
    Figure 37. North America Nivolumab Injection Sales Market Share by Type (2017-2028)
    Figure 38. North America Nivolumab Injection Revenue Market Share by Type (2017-2028)
    Figure 39. North America Nivolumab Injection Sales Market Share by Application (2017-2028)
    Figure 40. North America Nivolumab Injection Revenue Market Share by Application (2017-2028)
    Figure 41. North America Nivolumab Injection Sales Share by Country (2017-2028)
    Figure 42. North America Nivolumab Injection Revenue Share by Country (2017-2028)
    Figure 43. U.S. Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Nivolumab Injection Sales Market Share by Type (2017-2028)
    Figure 46. Europe Nivolumab Injection Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Nivolumab Injection Sales Market Share by Application (2017-2028)
    Figure 48. Europe Nivolumab Injection Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Nivolumab Injection Sales Share by Country (2017-2028)
    Figure 50. Europe Nivolumab Injection Revenue Share by Country (2017-2028)
    Figure 51. Germany Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 52. France Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Nivolumab Injection Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Nivolumab Injection Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Nivolumab Injection Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Nivolumab Injection Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Nivolumab Injection Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Nivolumab Injection Revenue Share by Region (2017-2028)
    Figure 62. China Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 65. India Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Nivolumab Injection Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Nivolumab Injection Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Nivolumab Injection Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Nivolumab Injection Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Nivolumab Injection Sales Share by Country (2017-2028)
    Figure 77. Latin America Nivolumab Injection Revenue Share by Country (2017-2028)
    Figure 78. Mexico Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Nivolumab Injection Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Nivolumab Injection Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Nivolumab Injection Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Nivolumab Injection Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Nivolumab Injection Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Nivolumab Injection Revenue Share by Country (2017-2028)
    Figure 87. Turkey Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Nivolumab Injection Revenue (2017-2028) & (US$ Million)
    Figure 90. Nivolumab Injection Value Chain
    Figure 91. Nivolumab Injection Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global and United States Blood Cancer Therapeutics Market Report Forecast 2022 2028
Global and United States Blood Cancer Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24U5687
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Ovarian Cancer Diagnostics Technologies Market Report Forecast 2022 2028
Global and United States Ovarian Cancer Diagnostics Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-23K5690
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Cancer Biotherapy Market Report Forecast 2022 2028
Global and United States Cancer Biotherapy Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-18N5929
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Emerging Cancer Diagnostics Market Report Forecast 2022 2028
Global and United States Emerging Cancer Diagnostics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-12C6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart